Comments on: Rilzabrutinib by Sanofi for Acquired (Autoimmune) Hemolytic Anemia: Likelihood of Approval /data-insights/rilzabrutinib-sanofi-acquired-autoimmune-hemolytic-anemia-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Tue, 18 Jun 2024 01:43:16 +0000 hourly 1 https://wordpress.org/?v=6.6.2